The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 02, 2024
Filed:
Sep. 12, 2022
Applicant:
Anjarium Biosciences Ag, Schlieren, CH;
Inventor:
Joel de Beer, Zollikon, CH;
Assignee:
Anjarium Biosciences AG, Schlieren, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 47/69 (2017.01); C07K 16/28 (2006.01); C12N 15/113 (2010.01); C12N 15/88 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1272 (2013.01); A61K 9/1271 (2013.01); A61K 9/1277 (2013.01); A61K 47/6911 (2017.08); A61K 47/6913 (2017.08); C07K 16/2896 (2013.01); C12N 15/113 (2013.01); C12N 15/88 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01); Y02A 50/30 (2018.01);
Abstract
The present invention provides a hybrid biocompatible carrier (hybridosome) which comprises structural and bioactive elements originating from at least one biocompatible delivery module (BDM) and at least one engineered drug encapsulation module (EDEM) comprising at least one tunable fusogenic moiety. The invention further provides pharmaceutical compositions comprising said hybridosomes, processes for their manufacture, as well as pharmaceutical uses and pharmaceutical methods based thereon.